210 related articles for article (PubMed ID: 12714514)
21. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
Gisbert JP; García-Buey L; Arranz R; Blas C; Pinilla I; Khorrami S; Acevedo A; Borque MJ; Pajares JM; Fernández-Rañada JM; Moreno-Otero R
Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):135-8. PubMed ID: 15075985
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA.
Gouda I; Nada O; Ezzat S; Eldaly M; Loffredo C; Taylor C; Abdel-Hamid M
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):29-34. PubMed ID: 19644357
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis.
Shariff S; Yoshida EM; Gascoyne RD; Le N; Connors JM; Middleton PJ; Shenkier TN
Ann Oncol; 1999 Aug; 10(8):961-4. PubMed ID: 10509159
[TBL] [Abstract][Full Text] [Related]
24. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
Dal Maso L; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
[TBL] [Abstract][Full Text] [Related]
27. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.
Luppi M; Longo G; Ferrari MG; Barozzi P; Marasca R; Morselli M; Valenti C; Mascia T; Vandelli L; Vallisa D; Cavanna L; Torelli G
Ann Oncol; 1998 May; 9(5):495-8. PubMed ID: 9653489
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
Ferri C; Caracciolo F; Zignego AL; La Civita L; Monti M; Longombardo G; Lombardini F; Greco F; Capochiani E; Mazzoni A
Br J Haematol; 1994 Oct; 88(2):392-4. PubMed ID: 7803287
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
Engels EA; Chatterjee N; Cerhan JR; Davis S; Cozen W; Severson RK; Whitby D; Colt JS; Hartge P
Int J Cancer; 2004 Aug; 111(1):76-80. PubMed ID: 15185346
[TBL] [Abstract][Full Text] [Related]
30. Role of hepatitis C virus infection in malignant lymphoma in Spain.
de Sanjose S; Nieters A; Goedert JJ; Domingo-Domenech E; Fernandez de Sevilla A; Bosch R; Herrera P; Domingo A; Petit J; Bosch X; Kallinowski B
Int J Cancer; 2004 Aug; 111(1):81-5. PubMed ID: 15185347
[TBL] [Abstract][Full Text] [Related]
31. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
Vallisa D; Bernuzzi P; Arcaini L; Sacchi S; Callea V; Marasca R; Lazzaro A; Trabacchi E; Anselmi E; Arcari AL; Moroni C; Bertè R; Lazzarino M; Cavanna L
J Clin Oncol; 2005 Jan; 23(3):468-73. PubMed ID: 15659492
[TBL] [Abstract][Full Text] [Related]
32. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.
De Vita S; Sacco C; Sansonno D; Gloghini A; Dammacco F; Crovatto M; Santini G; Dolcetti R; Boiocchi M; Carbone A; Zagonel V
Blood; 1997 Jul; 90(2):776-82. PubMed ID: 9226178
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
[TBL] [Abstract][Full Text] [Related]
34. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
[TBL] [Abstract][Full Text] [Related]
36. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?
Libra M; Polesel J; Russo AE; De Re V; Cinà D; Serraino D; Nicoletti F; Spandidos DA; Stivala F; Talamini R
Int J Oncol; 2010 Jun; 36(6):1331-40. PubMed ID: 20428756
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.
Gisbert JP; García-Buey L; Pajares JM; Moreno-Otero R
Gastroenterology; 2003 Dec; 125(6):1723-32. PubMed ID: 14724825
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus and lymphoma.
Paydas S
Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
